Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidiferphane and Taxanes in Breast Cancer
NCT03611985Phase 2Withdrawn
- Sponsor
- University of Florida
- Start
- Mar 2020
- Primary completion
- Mar 2023
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Epidiferphane in breast cancer, sponsored by University of Florida. Planned start Mar 2020; status: withdrawn.
02
Drugs
Epidiferphane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03611985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03611985.